Treatment of Hormone-Refractory Prostate Cancer With Docetaxel or Mitoxantrone: Relationships Between Prostate-Specific Antigen, Pain, and Quality of Life Response and Survival in the TAX-327 Study
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-0944
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2008
Authors
Publisher
American Association for Cancer Research (AACR)